CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,253,826
- in 9 filings, $2.1M under 10b5-1 plans
Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-02 | Turney Patricia A. SVP, Operations | Sale | −1,414 | $15.82 | $22K | 45,711 |
| 2023-03-02 | Turney Patricia A. SVP, Operations | Sale | −18 | $16.52 | $297 | 45,693 |
| 2023-03-02 | Watanabe Todd Franklin Director | Sale | −5,403 | $15.82 | $85K | 369,161 |
| 2023-03-02 | Watanabe Todd Franklin Director | Sale | −69 | $16.52 | $1K | 369,092 |
| 2023-03-02 | Burrows Scott L Chief Financial Officer | Sale | −1,416 | $15.82 | $22K | 38,424 |
| 2023-03-02 | Burrows Scott L Chief Financial Officer | Sale | −18 | $16.52 | $297 | 38,406 |
| 2023-03-02 | Lock Kenneth A. Chief Commercial Officer | Sale | −1,414 | $15.82 | $22K | 43,278 |
| 2023-03-02 | Lock Kenneth A. Chief Commercial Officer | Sale | −18 | $16.52 | $297 | 43,260 |
| 2023-03-02 | OSBORNE DAVID W Chief Technical Officer | Sale | −1,198 | $15.82 | $19K | 254,659 |
| 2023-03-02 | OSBORNE DAVID W Chief Technical Officer | Sale | −15 | $16.52 | $248 | 254,644 |
| 2023-02-28 | Turney Patricia A. SVP, Operations | Sale | −936 | $16.17 | $15K | 47,125 |
| 2023-02-28 | Watanabe Todd Franklin Director | Sale | −2,343 | $16.17 | $38K | 374,564 |
| 2023-02-28 | Burrows Scott L Chief Financial Officer | Sale | −416 | $16.17 | $7K | 39,840 |
| 2023-02-28 | Lock Kenneth A. Chief Commercial Officer | Sale | −936 | $16.17 | $15K | 44,692 |
| 2023-02-28 | OSBORNE DAVID W Chief Technical Officer | Sale | −792 | $16.17 | $13K | 255,857 |
| 2023-02-15 | Welgus Howard G. Director | Exercise or conversion | +8,500 | $1.68 | $14K | 174,325 |
| 2023-02-15 | Welgus Howard G. Director | Sale | −8,500 | $16.98 | $144K | 165,825 |
| 2023-02-15 | Welgus Howard G. Director | Exercise or conversion · Stock Option (right to buy) | −8,500 | 23,458 | ||
| 2023-02-14 | Watanabe Todd Franklin Director | Sale | −417 | $17.02 | $7K | 377,007 |
| 2023-02-14 | Watanabe Todd Franklin Director | Sale | −100 | $17.03 | $2K | 376,907 |
Page 26 of 35 · 689 trades